<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36949439</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>24</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1477-7525</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>22</Day></PubDate></JournalIssue><Title>Health and quality of life outcomes</Title><ISOAbbreviation>Health Qual Life Outcomes</ISOAbbreviation></Journal><ArticleTitle>What is the impact of post-COVID-19 syndrome on health-related quality of life and associated factors: a cross-sectional analysis.</ArticleTitle><Pagination><StartPage>28</StartPage><MedlinePgn>28</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">28</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12955-023-02107-z</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">After the acute phase, symptoms or sequelae related to post-COVID-19 syndrome may persist for months. In a population of patients, previously hospitalized and not, followed up to 12&#xa0;months after the acute infection, we aim to assess whether and to what extent post-COVID-19 syndrome may have an impact on health-related quality of life (HRQoL) and to investigate influencing factors.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We present the cross-sectional analysis of a prospective study, including patients referred to the post-COVID-19 service. Questionnaires and scales administered at 3, 6, 12&#xa0;months were: Short-Form 36-item questionnaire (SF-36); Visual Analogue Scale of the EQ5D (EQ-VAS); in a subgroup, Beck Anxiety Inventory (BAI), Beck Depression Inventory (BDI-II) and Pittsburgh Sleep Quality Index (PSQI). Linear regression models were fitted to identify factors associated with HRQoL.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We considered the first assessment of each participant (n&#x2009;=&#x2009;572). The mean scores in SF-36 and in EQ-VAS were significantly lower than the Italian normative values and remained stable over time, except the mental components score (MCS) of the SF-36 and EQ-VAS which resulted in lower ratings at the last observations. Female gender, presence of comorbidities, and corticosteroids treatment during acute COVID-19, were associated with lower scores in SF-36 and EQ-VAS; patients previously hospitalized (54%) reported higher MCS. Alterations in BAI, BDI-II, and PSQI (n&#x2009;=&#x2009;265)were associated with lower ratings in SF-36 and EQ-VAS.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study provides evidence of a significantly bad perception of health status among persons with post-COVID-19 syndrome, associated with female gender and, indirectly, with disease severity. In case of anxious-depressive symptoms and sleep disorders, a worse HRQoL was also reported. A systematic monitoring of these aspects is recommended to properly manage the post-COVID-19 period.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mastrorosa</LastName><ForeName>Ilaria</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0003-1944-662X</Identifier><AffiliationInfo><Affiliation>Clinical Department of Infectious Diseases and Research, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy. ilaria.mastrorosa@inmi.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Del Duca</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Clinical Department of Infectious Diseases and Research, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinnetti</LastName><ForeName>Carmela</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Clinical Department of Infectious Diseases and Research, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lorenzini</LastName><ForeName>Patrizia</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Clinical Department of Infectious Diseases and Research, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Center for Disease Prevention and Health Promotion, National Institute of Health, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vergori</LastName><ForeName>Alessandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Clinical Department of Infectious Diseases and Research, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brita</LastName><ForeName>Anna Clelia</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Psychology Service, Clinical Department of Infectious Diseases and Research, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Camici</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Clinical Department of Infectious Diseases and Research, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazzotta</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Clinical Department of Infectious Diseases and Research, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baldini</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Clinical Department of Infectious Diseases and Research, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chinello</LastName><ForeName>Pierangelo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Clinical Department of Infectious Diseases and Research, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mencarini</LastName><ForeName>Paola</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Clinical Department of Infectious Diseases and Research, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giancola</LastName><ForeName>Maria Letizia</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Clinical Department of Infectious Diseases and Research, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdeddaim</LastName><ForeName>Amina</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Clinical Department of Infectious Diseases and Research, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Girardi</LastName><ForeName>Enrico</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Scientific Direction, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vaia</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>General Direction, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antinori</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Clinical Department of Infectious Diseases and Research, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Health Qual Life Outcomes</MedlineTA><NlmUniqueID>101153626</NlmUniqueID><ISSNLinking>1477-7525</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Health-related quality of life</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Mental health</Keyword><Keyword MajorTopicYN="N">Neuropsychiatric symptoms</Keyword><Keyword MajorTopicYN="N">Physical health</Keyword><Keyword MajorTopicYN="N">Post-COVID-19 condition</Keyword><Keyword MajorTopicYN="N">Post-COVID-19 syndrome</Keyword><Keyword MajorTopicYN="N">Post-acute sequelae of COVID-19 infection (PASC)</Keyword><Keyword MajorTopicYN="N">Sleep disorders</Keyword><Keyword MajorTopicYN="N">The Short-Form 36-item questionnaire</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>23</Day><Hour>0</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36949439</ArticleId><ArticleId IdType="pmc">PMC10031164</ArticleId><ArticleId IdType="doi">10.1186/s12955-023-02107-z</ArticleId><ArticleId IdType="pii">10.1186/s12955-023-02107-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>National Institute for Health and Care Excellence (NICE), Scottish Intercollegiate Guidelines Network (SIGN) and Royal College of General Practitioners (RCGP) (2022, March 01). COVID19 rapid guideline: managing the long-term effects of COVID19. Retrieved May 15, 2022, from https://www.nice.org.uk/guidance/ng188/resources/covid19-rapid-guideline-managing-the-longterm-effects-of-covid19-pdf-51035515742 (2022).</Citation></Reference><Reference><Citation>Nasserie, T., Hittle, M., &amp; Goodman, S. N. Assessment of the Frequency and Variety of Persistent Symptoms Among Patients With COVID-19: A Systematic Review. JAMA network open, 4(5), e2111417. 10.1001/jamanetworkopen.2021.11417 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>The World Health Organization Quality of Life Assessment (WHOQOL): development and general psychometric properties. Social science &amp; medicine, 46(12), 1569&#x2013;1585. 10.1016/s0277-9536(98)00009-4 (1998).</Citation><ArticleIdList><ArticleId IdType="pubmed">9672396</ArticleId></ArticleIdList></Reference><Reference><Citation>Pequeno N, Cabral N, Marchioni DM, Lima S, Lyra CO. Quality of life assessment instruments for adults: a systematic review of population-based studies. Health Qual Life Outcomes. 2020;18(1):208. doi: 10.1186/s12955-020-01347-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12955-020-01347-7</ArticleId><ArticleId IdType="pmc">PMC7329518</ArticleId><ArticleId IdType="pubmed">32605649</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajan, S., et al. In the wake of the pandemic: Preparing for Long COVID. European Observatory on Health Systems and Policies. Retrieved May 15, 2022, from https://apps.who.int/iris/bitstream/handle/10665/339629/Policy-brief-39-1997-8073-eng.pdf (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">33877759</ArticleId></ArticleIdList></Reference><Reference><Citation>Nandasena, H., Pathirathna, M. L., Atapattu, A., &amp; Prasanga, P. Quality of life of COVID 19 patients after discharge: Systematic review. PloS one, 17(2), e0263941. 10.1371/journal.pone.0263941 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8849513</ArticleId><ArticleId IdType="pubmed">35171956</ArticleId></ArticleIdList></Reference><Reference><Citation>Poudel, A. N., et al. Impact of Covid-19 on health-related quality of life of patients: A structured review. PloS one, 16(10), e0259164. 10.1371/journal.pone.0259164 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8553121</ArticleId><ArticleId IdType="pubmed">34710173</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans RA, et al. Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study. Lancet Respir Med. 2021;9(11):1275&#x2013;1287. doi: 10.1016/S2213-2600(21)00383-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00383-0</ArticleId><ArticleId IdType="pmc">PMC8497028</ArticleId><ArticleId IdType="pubmed">34627560</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigfrid, L., et al. Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol. The Lancet regional health. Europe, 8, 100186. 10.1016/j.lanepe.2021.100186 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8343377</ArticleId><ArticleId IdType="pubmed">34386785</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker AM, et al. Addressing the post-acute sequelae of SARS-CoV-2 infection: a multidisciplinary model of care. Lancet Respir Med. 2021;9(11):1328&#x2013;1341. doi: 10.1016/S2213-2600(21)00385-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00385-4</ArticleId><ArticleId IdType="pmc">PMC8525917</ArticleId><ArticleId IdType="pubmed">34678213</ArticleId></ArticleIdList></Reference><Reference><Citation>Sintonen H. An approach to measuring and valuing health states. Soc Sci Med Med Econ. 1981;15(2):55&#x2013;65. doi: 10.1016/0160-7995(81)90019-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0160-7995(81)90019-8</ArticleId><ArticleId IdType="pubmed">7256314</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart, A.L., &amp; Ware J.E. Measuring functioning and well-being: the medical outcomes study approach. Duke university press, Durham and London. Psycho-Oncology, 4(2), 163&#x2013;163. 10.1002/pon.2960040212 (1992).</Citation></Reference><Reference><Citation>Apolone G, Mosconi P. The italian sf-36 health survey: translation, validation and norming. J Clin Epidemiol. 1998;51(11):1025&#x2013;1036. doi: 10.1016/s0895-4356(98)00094-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0895-4356(98)00094-8</ArticleId><ArticleId IdType="pubmed">9817120</ArticleId></ArticleIdList></Reference><Reference><Citation>Janssen MF, Szende A, Cabases J, Ramos-Go&#xf1;i JM, Vilagut G, K&#xf6;nig HH. Population norms for the EQ-5D-3L: a cross-country analysis of population surveys for 20 countries. The European journal of health economics: HEPAC: health economics in prevention and care. 2019;20(2):205&#x2013;216. doi: 10.1007/s10198-018-0955-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10198-018-0955-5</ArticleId><ArticleId IdType="pmc">PMC6438939</ArticleId><ArticleId IdType="pubmed">29445941</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;nig HH, et al. Comparison of population health status in six european countries: results of a representative survey using the EQ-5D questionnaire. Med Care. 2009;47(2):255&#x2013;261. doi: 10.1097/MLR.0b013e318184759e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MLR.0b013e318184759e</ArticleId><ArticleId IdType="pubmed">19169128</ArticleId></ArticleIdList></Reference><Reference><Citation>McHorney, C. A., Ware, J. E., Jr, &amp; Raczek, A. E. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Medical care, 31(3), 247&#x2013;263. 10.1097/00005650-199303000-00006 (1993).</Citation><ArticleIdList><ArticleId IdType="pubmed">8450681</ArticleId></ArticleIdList></Reference><Reference><Citation>Ware JE, Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473&#x2013;483. doi: 10.1097/00005650-199206000-00002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005650-199206000-00002</ArticleId><ArticleId IdType="pubmed">1593914</ArticleId></ArticleIdList></Reference><Reference><Citation>Lins L, Carvalho FM. SF-36 total score as a single measure of health-related quality of life: Scoping review. SAGE open medicine. 2016;4:2050312116671725. doi: 10.1177/2050312116671725.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2050312116671725</ArticleId><ArticleId IdType="pmc">PMC5052926</ArticleId><ArticleId IdType="pubmed">27757230</ArticleId></ArticleIdList></Reference><Reference><Citation>EuroQol Group EuroQol&#x2013;a new facility for the measurement of health-related quality of life. Health policy (Amsterdam, Netherlands) 1990;16(3):199&#x2013;208. doi: 10.1016/0168-8510(90)90421-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0168-8510(90)90421-9</ArticleId><ArticleId IdType="pubmed">10109801</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabin, R., &amp; de Charro, F. EQ-5D: a measure of health status from the EuroQol Group. Annals of medicine, 33(5), 337&#x2013;343. 10.3109/07853890109002087 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11491192</ArticleId></ArticleIdList></Reference><Reference><Citation>Long D, Polinder S, Bonsel GJ, Haagsma JA. Test-retest reliability of the EQ-5D-5L and the reworded QOLIBRI-OS in the general population of Italy, the Netherlands, and the United Kingdom. Qual Life Res. 2021;30(10):2961&#x2013;2971. doi: 10.1007/s11136-021-02893-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-021-02893-3</ArticleId><ArticleId IdType="pmc">PMC8481194</ArticleId><ArticleId IdType="pubmed">34075530</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck AT, Steer RA. Manual for the Beck anxiety inventory. San Antonio, TX: Psychological Corporation; 1990.</Citation></Reference><Reference><Citation>Sica C, Coradeschi D, Ghisi M, Sanavio E. The Italian adaptation of the BAI. In: Beck AT, Guide RA. Beck's Anxiety Inventory. Florence: Special Organizations; 2006.</Citation></Reference><Reference><Citation>Beck A, Steer R, Brown G. Beck Depression Inventory. 2. San Antonio, Tex, USA: The Psychological Corporation; 1996.</Citation></Reference><Reference><Citation>Ghisi M, Flebus GB, Montano A, Sanavio E, Sica C. Beck Depression Inventory. 2nd ed. Firenze: Organizzazioni Speciali; 2006.</Citation></Reference><Reference><Citation>Curcio G, et al. Validity of the Italian version of the Pittsburgh Sleep Quality Index (PSQI) Neurol Sci. 2013;34(4):511&#x2013;519. doi: 10.1007/s10072-012-1085-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-012-1085-y</ArticleId><ArticleId IdType="pubmed">22526760</ArticleId></ArticleIdList></Reference><Reference><Citation>Carenzo L, et al. Short-term health-related quality of life, physical function and psychological consequences of severe COVID-19. Ann Intensive Care. 2021;11(1):91. doi: 10.1186/s13613-021-00881-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-021-00881-x</ArticleId><ArticleId IdType="pmc">PMC8177269</ArticleId><ArticleId IdType="pubmed">34089104</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, et al. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324(6):603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>DE Lorenzo, R., et al. Physical and psychological sequelae at three months after acute illness in COVID-19 survivors.&#xa0;Panminerva medica, 10.23736/S0031-0808.21.04399-8. Epub ahead of print. 10.23736/S0031-0808.21.04399-8 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34060280</ArticleId></ArticleIdList></Reference><Reference><Citation>Monti G, et al. Two-months quality of life of COVID-19 invasively ventilated survivors; an Italian single-center study. Acta Anaesthesiol Scand. 2021;65(7):912&#x2013;920. doi: 10.1111/aas.13812.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aas.13812</ArticleId><ArticleId IdType="pmc">PMC8014684</ArticleId><ArticleId IdType="pubmed">33655487</ArticleId></ArticleIdList></Reference><Reference><Citation>Temperoni C, et al. Clinical characteristics, management and health related quality of life in young to middle age adults with COVID-19. BMC Infect Dis. 2021;21(1):134. doi: 10.1186/s12879-021-05841-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-021-05841-1</ArticleId><ArticleId IdType="pmc">PMC7848882</ArticleId><ArticleId IdType="pubmed">33522907</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen KY, Li T, Gong FH, Zhang JS, Li XK. Predictors of Health-Related Quality of Life and Influencing Factors for COVID-19 Patients, a Follow-Up at One Month. Front Psych. 2020;11:668. doi: 10.3389/fpsyt.2020.00668.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2020.00668</ArticleId><ArticleId IdType="pmc">PMC7360857</ArticleId><ArticleId IdType="pubmed">32733299</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, K., Zhang, W., Yang, Y., Zhang, J., Li, Y., &amp; Chen, Y. Respiratory rehabilitation in elderly patients with COVID-19: A randomized controlled study. Complementary therapies in clinical practice, 39, 101166. 10.1016/j.ctcp.2020.101166 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7118596</ArticleId><ArticleId IdType="pubmed">32379637</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Borst B, et al. Comprehensive Health Assessment 3 Months After Recovery From Acute Coronavirus Disease 2019 (COVID-19) Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2021;73(5):e1089&#x2013;e1098. doi: 10.1093/cid/ciaa1750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1750</ArticleId><ArticleId IdType="pmc">PMC7717214</ArticleId><ArticleId IdType="pubmed">33220049</ArticleId></ArticleIdList></Reference><Reference><Citation>Denton, M., Prus, S., &amp; Walters, V. Gender differences in health: a Canadian study of the psychosocial, structural and behavioural determinants of health.&#xa0;Social science &amp; medicine (1982),&#xa0;58(12), 2585&#x2013;2600. 10.1016/j.socscimed.2003.09.008 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15081207</ArticleId></ArticleIdList></Reference><Reference><Citation>Fodor, E., Lane, L., Schippers, J., &amp; van der Lippe, T. Gender Differences in Quality of Life. In: B&#xe4;ck-Wiklund M., van der Lippe T., den Dulk L., &amp; Doorne-Huiskes A. (eds) Quality of Life and Work in Europe. Palgrave Macmillan, London. 10.1057/9780230299443_9 (2011).</Citation></Reference><Reference><Citation>Lee KH, Xu H, Wu B. Gender differences in quality of life among community-dwelling older adults in low- and middle-income countries: results from the Study on global AGEing and adult health (SAGE) BMC Public Health. 2020;20(1):114. doi: 10.1186/s12889-020-8212-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-020-8212-0</ArticleId><ArticleId IdType="pmc">PMC6988191</ArticleId><ArticleId IdType="pubmed">31992264</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen, M., et al. Characterising long COVID: a living systematic review. BMJ global health, 6(9), e005427.10.1136/bmjgh-2021-005427 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Badenoch, J. B., et al. Persistent neuropsychiatric symptoms after COVID-19: a systematic review and meta-analysis.&#xa0;Brain communications,&#xa0;4(1), fcab297. 10.1093/braincomms/fcab297 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8833580</ArticleId><ArticleId IdType="pubmed">35169700</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukaetova-Ladinska EB, Kronenberg G. Psychological and neuropsychiatric implications of COVID-19. Eur Arch Psychiatry Clin Neurosci. 2021;271(2):235&#x2013;248. doi: 10.1007/s00406-020-01210-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00406-020-01210-2</ArticleId><ArticleId IdType="pmc">PMC7680256</ArticleId><ArticleId IdType="pubmed">33221936</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrozzino D, et al. Cross-cultural validity of the WHO-5 Well-Being Index and Euthymia Scale: A clinimetric analysis. J Affect Disord. 2022;311:276&#x2013;283. doi: 10.1016/j.jad.2022.05.111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2022.05.111</ArticleId><ArticleId IdType="pubmed">35609763</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrozzino, D., Patierno, C., Pignolo, C., &amp; Christensen, K. S. The concept of psychological distress and its assessment: A clinimetric analysis of the SCL-90-R.&#xa0;International Journal of Stress Management.&#xa0;Advance online publication.&#xa0;10.1037/str0000280 (2022).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>